FRAX在临床实践中按性别和骨质疏松定义的表现:马尼托巴BMD注册研究
该研究纳入62,275名女性和6455名男性,评估FRAX预测主要骨质疏松性骨折(MOF)和髋部骨折(HF)的表现是否受性别及WHO或NOF骨质疏松定义影响。结果显示FRAX对MOF和HF均有强预测力,性别交互无统计学意义,且在两种骨质疏松定义下表现均良好。
要点
- FRAX对MOF的HR(每SD):女性2.12,男性1.89,性别交互P=0.97。
- FRAX对HF的HR(每SD):女性4.78,男性4.20,性别交互P=0.71。
- 四个亚组间FRAX预测MOF的HR相似,女性亚组交互P=0.34,男性P=0.22。
核心结论
- FRAX在女性和男性中均为MOF和HF的强且一致的预测因子,且在WHO或NOF标准定义的骨质疏松者中表现良好。
研究设计与样本
- 研究纳入1996-2013年有基線髋部和脊柱DXA扫描的40岁及以上女性和男性,来自马尼托巴BMD注册研究。
- 个体被分为四个互不重叠的亚组:WHO标准骨质疏松、仅NOF标准骨质疏松、FRAX高骨折风险(MOF≥20%或HF≥3%且无骨质疏松)、低骨折风险(MOF<20%且HF<3%且无骨质疏松)。
- 在每个亚组中评估FRAX对 incident fracture 的分层能力(风险比[HR])和校准度(观察值与预测10年骨折概率)。
主要发现
- 人群包括62,275名女性(5345例MOF和1471例HF)和6455名男性(405例MOF和108例HF)。
- FRAX评分对MOF的HR(每SD):女性2.12(95%CI 2.06-2.18),男性1.89(95%CI 1.73-2.08),性别交互P=0.97。
- FRAX评分对HF的HR(每SD):女性4.78(95%CI 4.44-5.14),男性4.20(95%CI 3.22-5.49),性别交互P=0.71。
- 四个亚组间FRAX预测MOF的HR相似,女性亚组交互P=0.34,男性亚组交互P=0.22。
- 定义亚组的观察值与预测10年MOF和HF概率在女性和男性中均高度一致(所有r²≥0.9)。
关键数值与推荐
- FRAX高骨折风险定义为MOF≥20%或HF≥3%且无骨质疏松。
- 低骨折风险定义为MOF<20%且HF<3%且无骨质疏松。
- 骨质疏松定义采用WHO标准或NOF标准。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Among 62,275 women and 6455 men, FRAX stratified risk for incident major osteoporotic fracture (MOF) and incident hip fracture (HF) without sex interaction. Performance was good in those with osteoporosis regardless of how this was defined. INTRODUCTION: Some studies have reported that FRAX performance differs according to sex and/or osteoporosis definitions. We evaluated whether the performance of FRAX to predict incident MOF and HF in women and men was affected by the presence or absence of osteoporosis defined by World Health Organization (WHO) or National Osteoporosis Foundation (NOF) criteria. METHODS: We studied women and men age ≥ 40 years with baseline hip and spine DXA scans (1996-2013). Individuals were classified into four non-overlapping subgroups: osteoporosis by WHO criteria, osteoporosis exclusively by NOF criteria, high fracture risk by FRAX (MOF ≥ 20% or HF ≥ 3%, without osteoporosis), and low fracture risk (MOF < 20% and HF < 3% without osteoporosis). In each subgroup, we evaluated stratification (hazard ratios [HR]) and calibration (observed vs predicted 10-year fracture probability) for incident fracture. RESULTS: The population included 62,275 women (5345 MOF and 1471 HF) and 6455 men (405 MOF and 108 HF). FRAX scores were strongly predictive of MOF (HR per SD: women 2.12, 95% CI 2.06-2.18; men 1.89, 95% CI 1.73-2.08; sex interaction p value = 0.97) and HF (women 4.78, 95% CI 4.44-5.14; men 4.20, 95% CI 3.22-5.49; sex interaction p value = 0.71). FRAX scores gave similar HRs for MOF among the four subgroups (subgroup interaction p value 0.34 for women, 0.22 for men). Observed versus predicted 10-year MOF and HF probability for the defined subgroups demonstrated a high level of concordance for women and men (all r2 ≥ 0.9). CONCLUSIONS: FRAX was a strong and consistent predictor of MOF and HF in both women and men and performed well in those with osteoporosis whether defined by WHO or NOF criteria.
引用
- Leslie WD, Majumdar SR, Morin SN, et al. Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry. Osteoporos Int. 2018. PMID: 29404625. doi:10.1007/s00198-018-4415-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。